Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Identify whether an SP 500 ETF or index fund better suits your retirement plan, focusing on costs and long-term goals.
25,310 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Sunoco LP is redefining its business, shifting from fueling pumps to a broader energy platform. With 2026 EBITDA guid...
A federal judge pressed the government over its bid to block Anthropic’s AI from top-secret systems. The hearing unde...
President Trump issues an emergency payroll directive for TSA workers as the DHS shutdown drags on, hoping to relieve...
New Hampshire lawmakers pivot from a sweeping pro-housing mandate to targeted reforms after local pushback. HB1010 mo...
The White House has tapped a former private-prison executive to head ICE on an acting basis, narrowing leadership gap...
KBR has endured a tough year, with the stock fallen this past year by about 45%. A fresh stake worth $24 million from...
Two entertainment giants, Netflix and Disney, are navigating a fast-changing landscape. This analysis breaks down rec...
Developers race to add native privacy to Ethereum as investors rotate into privacy-first assets. A 12-month deadline ...
A new study finds Republican lawmakers are increasingly tilting their portfolios toward Bitcoin and related crypto as...
SpaceX has not announced an IPO date, but growing chatter centers on whether retail investors could drive a future pu...
Strategy shareholders approved a plan to start semi-monthly dividends on STRC preferred stock, aiming to steady price...